May 08, 2024 / 08:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the Royal mater Therapeutics, Inc. First Quarter 2024 financial results conference call. At this time, all lines are in listen only mode following the presentation, we'll conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the offer call is being recorded on Wednesday, May eighth, 2024.
I would now like to turn the conference over to Tim McCarthy, LifeSci Advisors. Please go ahead.
Tim McCarthy - LifeSci Advisors, LLC - IR
Thank you, Colin, and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Sergio Theresa, and Chief Financial Officer magazine.
Earlier this afternoon, Renato issued a press release providing a business update and announcing financial results for the three months ended March 31st, 2024. Please note that certain information discussed on the call today is covered under the Safe Harbor provision of the Private Securities Litigation Reform Act. We
Q1 2024 Relmada Therapeutics Inc Earnings Call Transcript
May 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers